APOE and Alzheimer disease: When genotyping FKBP5 in an AD cohort, a synergistic effect of its alleles and the APOE genotype on anxiety scores and a sex‐dependent effect of FKBP5 promoter methylation on neurophysiological brain activity has been observed.55